Cryoport's Portfolio

... Read more

CTI BioPharma And

... Read more

Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO

... Read more

Cyclacel Reports Updated Data From Its DNA Damage Response Program on Seliciclib

... Read more

CymaBay Announces Positive Interim Results from Its Ongoing Low-Dose

... Read more

Read more

Cynapsus Therapeutics Provides Clinical and Regulatory Update for APL-130277 for the Acute Rescue of OFF Motor Symptoms of

... Read more

Cyprium Mining

... Read more

Cytori and Lorem Vascular

... Read more

CytRx Announces Positive

... Read more